Onxeo

Onxeo's email is contact@onxeo.com and Onxeo's phone number is 330145587600 .
Onxeo is a biotechnology company that develops drugs for oncology. It offers Beleodaq, a histone deactylase inhibitor for the treatment of peripheral T-cell lymphoma; Livatag, a nanoparticle formulation of doxorubicin, which is in Phase III clinical trials for the treatment of primary liver cancer; Validive, a mucoadhesive buccal tablet that is in Phase II clinical trials for the prevention and the treatment of chemoradioation therapy-induced severe oral mucositis in patients with head and neck cancer; and Combo BelCHOP, which is Phase II clinical trials for the treatmen...

read more

Onxeo is a biotechnology company that develops drugs for oncology. It offers Beleodaq, a histone deactylase inhibitor for the treatment of peripheral T-cell lymphoma; Livatag, a nanoparticle formulation of doxorubicin, which is in Phase III clinical trials for the treatment of primary liver cancer; Validive, a mucoadhesive buccal tablet that is in Phase II clinical trials for the prevention and the treatment of chemoradioation therapy-induced severe oral mucositis in patients with head and neck cancer; and Combo BelCHOP, which is Phase II clinical trials for the treatment of peripheral T-cell lymphoma. Onxeo is headquartered in Paris, France.

show less

View Top Employees for Onxeo
img Industry Pharmaceuticals
img Location Paris, île De France, France
img Employees 40
img Founded 2014
img HQ 49 Boulevard du Général Martial Valin
img Phone 33014-558-7600
img Email contact@onxeo.com
img Funding 60,395,000 EUR
img Competitors Walgreens Boots Allia..., Pfizer, Cvs Health, Novartis, Gsk, Bayer,
img Industry Pharmaceuticals
img Location Paris, île De France, France
img Employees 40
img Founded 2014
img LinkedIn linkedin.com/company/bioalliance-pharma
img HQ 49 Boulevard du Général Martial Valin
img Phone 33014-558-7600
img Email contact@onxeo.com
img Funding 60,395,000 EUR

Top Competitors